Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03329950
Title A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celldex Therapeutics

ovarian cancer

liver cancer



transitional cell carcinoma

esophageal cancer

breast cancer

fallopian tube cancer

colorectal cancer

pancreatic adenocarcinoma

lung non-small cell carcinoma

stomach cancer

renal cell carcinoma

peritoneum cancer

head and neck cancer


CDX-1140 + CDX-301


Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Insititute Recruiting Scottsdale Arizona 85258 United States Details
Northside Hospital, Inc. Recruiting Atlanta Georgia 30342 United States Details
Georgia Cancer Center at Augusta University Recruiting Augusta Georgia 30912 United States Details
Oncology Hematology West, PC dba Nebraska Cancer Specialists Recruiting Omaha Nebraska 68130 United States Details
Icahn School of Medicine at Mount Sinai Recruiting New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Gabrail Cancer Center Research LLC Recruiting Canton Ohio 44718 United States Details
Providence Portland Medical Center Recruiting Portland Oregon 97213 United States Details
Abramson Cancer Center at the University of Pennsylvania Recruiting Philadelphia Pennsylvania 19104 United States Details
Rhode Island Hospital (RIH) The Miriam Hospital (TMH) Recruiting Providence Rhode Island 02903 United States Details
Houston Methodist Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field